IMG - CIMG Inc. Stock Analysis | Stock Taper
Logo
CIMG Inc.

IMG

CIMG Inc. NASDAQ
$0.48 0.25% (+0.00)

Market Cap $4.32 M
52w High $13.84
52w Low $0.45
P/E -0.17
Volume 118.37K
Outstanding Shares 8.99M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $10.24M $1.94M $-1.89M -18.49% $-0.19 $-2.41M
Q3-2025 $61.58K $1.1M $-1.07M -1.74K% $-0.03 $-1.05M
Q2-2025 $0 $752.68K $-385.56K 0% $-0.03 $-377.88K
Q1-2025 $0 $752.68K $-385.56K 0% $-0.03 $-377.88K
Q4-2024 $22.85K $1.52M $-1.54M -6.72K% $-0.17 $-1.53M

What's going well?

The company finally generated significant revenue, jumping from almost nothing to over $10 million. Gross profit turned positive, showing some ability to cover basic costs. Efficiency improved as expenses didn't rise as fast as sales.

What's concerning?

Losses are still large and getting bigger, both in total dollars and per share. Margins are extremely thin, and the business is still far from profitability. The sharp drop in share count could signal a reverse split, which often worries investors.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $55.14M $72.62M $23.09M $48.65M
Q3-2025 $2.4K $13.1M $2.48M $10.64M
Q2-2025 $2.4K $13.1M $2.48M $10.64M
Q1-2025 $2.4K $13.1M $2.48M $10.64M
Q4-2024 $124.72K $5.17M $3.64M $1.53M

What's financially strong about this company?

IMG has over $55 billion in cash and investments, almost no debt, and a very high ratio of liquid assets to liabilities. The balance sheet is extremely strong and flexible, with little risk from debt or hidden obligations.

What are the financial risks or weaknesses?

Retained earnings are deeply negative, showing large past losses. The company has almost no physical assets, so its value is mostly in cash and investments. The big jump in equity and cash may be from a one-time event, not ongoing profits.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $-1.9M $-6.36M $2.67K $6.28M $101.33K $-6.36M
Q3-2025 $-385.56K $-8.96M $12.77K $8.88M $-122.31K $-8.96M
Q2-2025 $-385.56K $-8.96M $12.77K $8.88M $-122.31K $-8.96M
Q1-2025 $-385.56K $-8.96M $12.77K $8.88M $-122.31K $-8.96M
Q4-2024 $-7.1M $-6.14M $-9.7K $5.96M $89.76K $-6.15M

Revenue by Geography

Region Q1-2025Q2-2025Q3-2025Q4-2025
CHINA
CHINA
$0 $0 $0 $10.00M

5-Year Trend Analysis

A comprehensive look at CIMG Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

The company’s recent profile combines several positives: explosive top‑line growth, steadily narrowing accounting losses, and a sharply strengthened balance sheet with more cash and less debt. Strategically, it has moved away from a narrow legacy coffee business into higher‑growth, technology‑driven fields like AI marketing, digital health, crypto, computing power, and biopharma, supported by creative moves such as tokenizing its equity and holding a significant Bitcoin reserve. This positioning, plus strong current liquidity, gives management room to pursue ambitious plans and potentially reshape the business around more scalable, tech‑enabled revenue streams.

! Risks

Key risks remain substantial. The business is still not profitable on either an earnings or a cash flow basis, with a long history of cumulative losses and no established track record of generating positive free cash flow. The capital structure and asset base have been highly volatile and heavily influenced by external financing and acquisitions. Strategically, the company is spread across multiple complex and regulated sectors, each with strong entrenched competitors, while reporting no traditional R&D spending and limited disclosure on proprietary technology. Regulatory, integration, and execution risks are all elevated, and the business could be vulnerable if capital markets support weakens or if new initiatives fail to scale as planned.

Outlook

The overall outlook is that of a speculative turnaround and reinvention story. Financial trends on the income statement and balance sheet are moving in the right direction—higher revenue, smaller losses, more cash, and less debt—but the underlying engine of sustainable, cash‑generating operations is not yet in place. If CIMG can harness its diversified innovations, execute on digital health, AI, computing, and biopharma opportunities, and convert rapid top‑line growth into durable margins and positive cash flow, its recent transformation could gain real traction. Until then, the company’s future path remains highly dependent on continued access to capital and successful execution across several ambitious, high‑risk initiatives at once.